Multiple Myeloma Research Review, Issue 67
In this issue:
MRD-CR is a viable intermediate end point in MM
MRD model considering MRD dynamics predicts long-term outcomes
NK composition may be a biomarker of response to daratumumab
Personalised dynamic risk assessment based on transcriptional profiling
Cilta-cel outperforms ide-cel in realworld but is more toxic
Sequential CAR T-cell therapy: salvage anti-GPRC5D promising after anti-BCMA
MonumenTAL-1: High and durable responses to talquetamab in RRMM
Myeloma immune evasion may not be due to T-cell dysfunction
Tregs at diagnosis as a biomarker for functionally high-risk disease
ALCYONE: D-VMP improves survival in transplant-ineligible patients
Expert contributor
Professor Philip Campbell
Professor Philip Campbell is a general haematologist with broad training and experience in malignant and non-malignant haematology. His main clinical interests are malignant haematology and clinical research, particularly multicentre collaborative research in malignant haematology. His current appointments are Clinical Associate Professor, Deakin University Medical School, and Clinical Haematologist, Andrew Love Cancer Centre, Geelong Hospital, Barwon […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.